Brazil approves marijuana derivative for medical treatment

January 14, 2015 byAdriana Gomez Licon
In this Dec. 18, 2014 file photo, relatives and friends of patients protest for the legalization of cannabidiol, a marijuana derivative that's banned in Brazil, outside the Health Surveillance Agency (ANVISA) in Brasilia, Brazil. On Wednesday, Jan. 14, 2015, for the first time Brazil approved the use of the marijuana derivative to treat people suffering from epilepsy, multiple sclerosis and schizophrenia among other disorders. (AP Photo/Eraldo Peres, File)

Brazil on Wednesday for the first time approved the use of a marijuana derivative to treat people suffering from severe seizures and other conditions.

Directors of the country's Health Surveillance Agency recognized the therapeutic properties of cannabidiol, saying it is now a "controlled" substance and no longer illegal.

It can now be used to treat epilepsy, multiple sclerosis and schizophrenia among other disorders.

Cannabidiol is not produced in Brazil and the agency said it will draw up legislation permitting it to be imported.

"We had a technical and scientific discussion of a matter that is often influenced by other issues and biases," the agency's president Jaime Oliveira told reporters.

He said cannabidiol does not cause dependency nor psychoactive effects on users.

"It is a great first step but we still need easier and less expensive access to the medication," said Margarete de Brito who gives cannabidiol to her 6-year-old daughter Sofia who was born with a genetic mutation that causes seizures.

Last month, the Federal Medical Council that regulates the medical profession in Brazil authorized neurologists and psychiatrists to prescribe cannabidiol to treat epileptic children and teenagers who do not respond to conventional treatment.

Explore further: Brazil to study legalization of medical marijuana

Related Stories

Brazil to study legalization of medical marijuana

December 19, 2014
Brazil will soon look into the possibility of legalizing the use of a marijuana derivative to treat people suffering from severe seizures.

Marijuana component could ease pain from chemotherapy drugs

October 6, 2011
A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.

France seeks to stamp out first e-joint (Update)

December 16, 2014
France sought to stamp out a new electronic cigarette containing cannabis, launched Tuesday with the claim it provides all of the relaxation but none of the mind-altering effects of marijuana.

Could cannabis curb seizures? Experts weed through the evidence

May 22, 2014
The therapeutic potential of medical marijuana and pure cannabidiol (CBD), an active substance in the cannabis plant, for neurologic conditions is highly debated. A series of articles published in Epilepsia, a journal of ...

First cannabis-derived drug authorised for France

January 9, 2014
France has for the first time approved prescription use of a drug derived from cannabis—a mouth spray used to treat multiple sclerosis (MS) symptoms, the government said Thursday.

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.